{
  "experiment_info": {
    "experiment_name": "paper_14_A_Computational",
    "run_number": 10,
    "total_runs": 10,
    "timestamp": "20250623_220414",
    "run_start_time": "2025-06-23T23:19:43.054957",
    "run_end_time": "2025-06-23T23:20:06.716379"
  },
  "inputs": {
    "initial_description": {
      "timestamp": "2025-06-23T23:19:43.055957",
      "data": {
        "description": "Vascular development is a complex process regulated by dynamic biological networks that vary in topology and state across different tissues and developmental stages. Signals regulating de novo blood vessel formation (vasculogenesis) and remodeling (angiogenesis) come from a variety of biological pathways linked to endothelial cell (EC) behavior, extracellular matrix (ECM) remodeling and the local generation of chemokines and growth factors. Simulating these interactions at a systems level requires sufficient biological detail about the relevant molecular pathways and associated cellular behaviors, and tractable computational models that offset mathematical and biological complexity. Here, we describe a novel multicellular agent-based model of vasculogenesis using the CompuCell3D (http://www.compucell3d.org/) modeling environment supplemented with semi-automatic knowledgebase creation. The model incorporates vascular endothelial growth factor signals, pro- and anti-angiogenic inflammatory chemokine signals, and the plasminogen activating system of enzymes and proteases linked to ECM interactions, to simulate nascent EC organization, growth and remodeling. The model was shown to recapitulate stereotypical capillary plexus formation and structural emergence of non-coded cellular behaviors, such as a heterologous bridging phenomenon linking endothelial tip cells together during formation of polygonal endothelial cords. Molecular targets in the computational model were mapped to signatures of vascular disruption derived from in vitro chemical profiling using the EPA's ToxCast high-throughput screening (HTS) dataset. Simulating the HTS data with the cell-agent based model of vascular development predicted adverse effects of a reference anti-angiogenic thalidomide analog, 5HPP-33, on in vitro angiogenesis with respect to both concentration-response and morphological consequences. These findings support the utility of cell agent-based models for simulating a morphogenetic series of events and for the first time demonstrate the applicability of these models for predictive toxicology."
      }
    }
  },
  "llm_responses": [
    {
      "step": "llm_response",
      "timestamp": "2025-06-23T23:19:52.992882",
      "prompt": "Original description: Vascular development is a complex process regulated by dynamic biological networks that vary in topology and state across different tissues and developmental stages. Signals regulating de novo blood vessel formation (vasculogenesis) and remodeling (angiogenesis) come from a variety of biological pathways linked to endothelial cell (EC) behavior, extracellular matrix (ECM) remodeling and the local generation of chemokines and growth factors. Simulating these interactions at a systems level requires sufficient biological detail about the relevant molecular pathways and associated cellular behaviors, and tractable computational models that offset mathematical and biological complexity. Here, we describe a novel multicellular agent-based model of vasculogenesis using the CompuCell3D (http://www.compucell3d.org/) modeling environment supplemented with semi-automatic knowledgebase creation. The model incorporates vascular endothelial growth factor signals, pro- and anti-angiogenic inflammatory chemokine signals, and the plasminogen activating system of enzymes and proteases linked to ECM interactions, to simulate nascent EC organization, growth and remodeling. The model was shown to recapitulate stereotypical capillary plexus formation and structural emergence of non-coded cellular behaviors, such as a heterologous bridging phenomenon linking endothelial tip cells together during formation of polygonal endothelial cords. Molecular targets in the computational model were mapped to signatures of vascular disruption derived from in vitro chemical profiling using the EPA's ToxCast high-throughput screening (HTS) dataset. Simulating the HTS data with the cell-agent based model of vascular development predicted adverse effects of a reference anti-angiogenic thalidomide analog, 5HPP-33, on in vitro angiogenesis with respect to both concentration-response and morphological consequences. These findings support the utility of cell agent-based models for simulating a morphogenetic series of events and for the first time demonstrate the applicability of these models for predictive toxicology.\n\nClarifications provided: \n\n\n    Return ONLY a JSON object with ontology annotations. Format all IDs and terms exactly as specified in the system message.",
      "system_message": "You are a biological modeling expert. Create structured ontology annotations based on the provided information. \n    Include relevant Cell Ontology, GO, and MeSH terms where applicable.\n    Return ONLY a JSON object with categories for different ontology types.\n    \n    Format requirements:\n    1. Category names must be exact:\n       - \"CellOntology\" (not \"Cell Ontology\" or \"Cell  Ontology\")\n       - \"GeneOntology\" (not \"Gene Ontology\" or \"Gene  Ontology\")\n       - \"MeSH\" (not \"MeSH Terms\" or \"MeSH  Terms\")\n    \n    2. Ontology IDs must be exact without spaces:\n       - Cell Ontology: \"CL:0000000\" (not \"CL : 000 000 0\")\n       - Gene Ontology: \"GO:0000000\" (not \"GO : 000 000 0\")\n       - MeSH: \"D000000\" (not \"D 000 000\")\n    \n    3. Term names must be exact without extra spaces:\n       - \"Epithelial\" (not \"Ep ith elial\")\n       - \"Mesenchymal\" (not \"Mes ench ym al\")\n    \n    Example format:\n    {\n        \"CellOntology\": [\n            {\n                \"id\": \"CL:0000000\",\n                \"term\": \"Epithelial\"\n            }\n        ],\n        \"GeneOntology\": [\n            {\n                \"id\": \"GO:0000000\",\n                \"term\": \"Cell Division\"\n            }\n        ],\n        \"MeSH\": [\n            {\n                \"id\": \"D000000\",\n                \"term\": \"Cell Proliferation\"\n            }\n        ]\n    }\n    \n    Do not include any explanations or thinking process.",
      "response": "<think>\nOkay, let's break down the problem. The user wants structured ontology annotations based on the provided biological description. The task is to identify relevant terms from Cell Ontology (CL), Gene Ontology (GO), and MeSH, ensuring the exact formatting of category names, IDs, and terms.\n\nFirst, I need to parse the original description for key biological concepts. The main focus is on vascular development, involving endothelial cells (ECs), extracellular matrix (ECM), vasculogenesis, angiogenesis, growth factors like VEGF, chemokines, enzymes such as plasminogen activators, and terms related to computational modeling and toxicology.\n\nStarting with Cell Ontology. The text mentions endothelial cells, so \"endothelial cell\" is a term here. Checking Cell Ontology, the correct ID for endothelial cell is CL:0000115. So that's one entry for CellOntology.\n\nNext, Gene Ontology. Processes involved include vasculogenesis (GO:0001570), angiogenesis (GO:0001525), extracellular matrix organization (GO:0030198), and cell proliferation (GO:0008283). These are all GO terms related to the biological processes described. Also, the plasminogen activating system involves proteolysis (GO:0006508). VEGF signaling pathway is another GO term (GO:0048010). So those would be the GO entries.\n\nFor MeSH terms, the main concepts are vascular development (MeSH D014655), extracellular matrix (D005109), endothelial cells (D004727), angiogenesis (D000096), growth factors (D005786), and toxicology (D014050). Additionally, computational models and high-throughput screening might fall under \"Models, Biological\" (D008957) and \"High-Throughput Screening Assays\" (D059748). Thalidomide analogs are mentioned, so \"Thalidomide\" (D013792) could be relevant. \n\nNeed to ensure all IDs are correctly formatted without spaces. Also, term names must match exactly. For example, \"Vascular Development\" in MeSH is D014655. Check each term against their respective ontologies to confirm IDs and exact term names. Make sure there are no typos or extra spaces in the terms. Also, verify that categories are named exactly as specified: \"CellOntology\", \"GeneOntology\", \"MeSH\".\n\nFinally, assemble the JSON object following the example structure, ensuring that each category has the correct entries with proper IDs and terms. Double-check for any formatting issues, like commas and brackets. Make sure there are no explanations, just the JSON object.\n</think>\n\n{\n    \"CellOntology\": [\n        {\n            \"id\": \"CL:0000115\",\n            \"term\": \"endothelial cell\"\n        }\n    ],\n    \"GeneOntology\": [\n        {\n            \"id\": \"GO:0001570\",\n            \"term\": \"vasculogenesis\"\n        },\n        {\n            \"id\": \"GO:0001525\",\n            \"term\": \"angiogenesis\"\n        },\n        {\n            \"id\": \"GO:0030198\",\n            \"term\": \"extracellular matrix organization\"\n        },\n        {\n            \"id\": \"GO:0008283\",\n            \"term\": \"cell proliferation\"\n        },\n        {\n            \"id\": \"GO:0006508\",\n            \"term\": \"proteolysis\"\n        },\n        {\n            \"id\": \"GO:0048010\",\n            \"term\": \"vascular endothelial growth factor receptor signaling pathway\"\n        }\n    ],\n    \"MeSH\": [\n        {\n            \"id\": \"D014655\",\n            \"term\": \"Vascular Development\"\n        },\n        {\n            \"id\": \"D005109\",\n            \"term\": \"Extracellular Matrix\"\n        },\n        {\n            \"id\": \"D004727\",\n            \"term\": \"Endothelial Cells\"\n        },\n        {\n            \"id\": \"D000096\",\n            \"term\": \"Angiogenesis\"\n        },\n        {\n            \"id\": \"D005786\",\n            \"term\": \"Growth Factors\"\n        },\n        {\n            \"id\": \"D008957\",\n            \"term\": \"Models, Biological\"\n        },\n        {\n            \"id\": \"D014050\",\n            \"term\": \"Toxicology\"\n        },\n        {\n            \"id\": \"D059748\",\n            \"term\": \"High-Throughput Screening Assays\"\n        },\n        {\n            \"id\": \"D013792\",\n            \"term\": \"Thalidomide\"\n        }\n    ]\n}"
    },
    {
      "step": "llm_response",
      "timestamp": "2025-06-23T23:20:06.688433",
      "prompt": "Generate a valid CompuCell3D simulation file based on these ontology annotations.\n    Return ONLY the Python code:\n\n{'CellOntology': {'endothelial cell (CL:0000115)'}, 'GeneOntology': {'vasculogenesis (GO:0001570)', 'angiogenesis (GO:0001525)', 'vascular endothelial growth factor receptor signaling pathway (GO:0048010)', 'cell proliferation (GO:0008283)', 'proteolysis (GO:0006508)', 'extracellular matrix organization (GO:0030198)'}, 'MeSH': {'Models, Biological (D008957)', 'Vascular Development (D014655)', 'Extracellular Matrix (D005109)', 'High-Throughput Screening Assays (D059748)', 'Angiogenesis (D000096)', 'Growth Factors (D005786)', 'Toxicology (D014050)', 'Endothelial Cells (D004727)', 'Thalidomide (D013792)'}}",
      "system_message": "You are a CompuCell3D expert. Generate a valid CompuCell3D simulation file.\n    Return ONLY the Python code without any additional text, explanations, or thinking process.\n    The code must include:\n    1. Required imports (CompuCellSetup, steppables)\n    2. A proper simulation class that inherits from steppables.SteppableBasePy\n    3. Required methods (__init__, start, step)\n    4. Basic cell types and parameters based on the ontology annotations",
      "response": "<think>\nOkay, I need to generate a CompuCell3D simulation file based on the given ontology annotations. Let's start by breaking down the requirements.\n\nFirst, the user specified several Cell Ontology terms, mainly endothelial cells. So the simulation should include this cell type. Maybe define it in the XML or directly in the Python code. Since the code needs to be self-contained, I'll set up the cell types in the start method.\n\nLooking at the Gene Ontology terms: vasculogenesis, angiogenesis, VEGF signaling, cell proliferation, proteolysis, and extracellular matrix organization. These processes suggest that the simulation should involve cell movement, growth, maybe some chemotaxis towards a growth factor, and ECM interactions. I'll need to include a VEGF field for chemotaxis and possibly ECM degradation via proteolysis.\n\nThe MeSH terms mention Vascular Development, Extracellular Matrix, Growth Factors (like VEGF), Endothelial Cells, and Thalidomide. Thalidomide is known for inhibiting angiogenesis, so maybe include a drug effect, but the user didn't specify, so perhaps just the basic elements. Focus on VEGF and ECM.\n\nNow, the structure of a CompuCell3D simulation file: imports, simulation class inheriting from SteppableBasePy, __init__, start, step methods. Also, basic cell types and parameters based on the ontology.\n\nStart by importing necessary modules: CompuCellSetup, steppables, and maybe cc3d for core elements.\n\nIn the simulation class, the __init__ method should call the parent's __init__. The start method is where I'll set up the cell types (endothelial), configure the volume and contact energy parameters. Also, add a chemical field for VEGF.\n\nIn the step method, implement cell behaviors: proliferation (maybe using the length constraint to grow and divide), chemotaxis towards VEGF, and possibly ECM degradation (though that might require more complex handling, like modifying the field or cell motility based on ECM).\n\nSet up the XML parameters via the generate_xml_config method. Include plugins for Volume, Contact, Chemotaxis (towards VEGF), and maybe LengthConstraint for proliferation. Also, add a steppable for the simulation class.\n\nMake sure the code is valid, includes all required parts, and doesn't have any extra explanations. Check for correct method names and parameters. Use the correct syntax for adding cell types, setting up fields, and configuring plugins.\n</think>\n\n```python\nfrom cc3d import CompuCellSetup\nfrom cc3d.core.PySteppables import SteppableBasePy, Dim3D\nfrom cc3d.core.XMLUtils import ElementCC3D\n\nclass VascularSimulation(SteppableBasePy):\n    def __init__(self, frequency=1):\n        super().__init__(frequency)\n        self.vegf_field = None\n        \n    def start(self):\n        # Define cell types\n        self.cell_type_endothelial = self.new_cell_type(\"Endothelial\")\n        \n        # Configure basic cell parameters\n        volume_params = ElementCC3D(\"VolumeEnergyParameters\")\n        volume_params.ElementCC3D(\"TargetVolume\", {}, 25)\n        volume_params.ElementCC3D(\"LambdaVolume\", {}, 2.0)\n        self.cc3d.addElement(volume_params)\n        \n        contact_params = ElementCC3D(\"ContactEnergy\")\n        contact_params.ElementCC3D(\"Energy\", {\"Type1\": \"Medium\", \"Type2\": \"Endothelial\"}, 5)\n        contact_params.ElementCC3D(\"Energy\", {\"Type1\": \"Endothelial\", \"Type2\": \"Endothelial\"}, 15)\n        self.cc3d.addElement(contact_params)\n        \n        # Add VEGF chemotaxis\n        self.vegf_field = self.add_chemical_field(\"VEGF\")\n        chemotaxis_params = ElementCC3D(\"Chemotaxis\")\n        chemotaxis_plugin = chemotaxis_params.ElementCC3D(\"Plugin\", {\"Name\": \"Chemotaxis\"})\n        chem_data = chemotaxis_plugin.ElementCC3D(\"ChemicalField\", {\"Name\": \"VEGF\"})\n        chem_data.ElementCC3D(\"Lambda\", {}, 1000)\n        self.cc3d.addElement(chemotaxis_params)\n        \n        # Configure cell cycle and proliferation\n        length_constraint = ElementCC3D(\"LengthConstraint\")\n        length_constraint.ElementCC3D(\"Length\", {}, 20)\n        self.cc3d.addElement(length_constraint)\n        \n    def step(self, mcs):\n        for cell in self.cell_list:\n            if cell.type == self.cell_type_endothelial:\n                # Simulate VEGF-driven chemotaxis\n                self.chemotaxis_plugin.setLambda(cell, 1000)\n                \n                # Simulate cell proliferation\n                if mcs % 50 == 0 and cell.volume > 30:\n                    self.divide_cell_random_orientation(cell)\n                \n                # ECM degradation through protease activity\n                if mcs % 10 == 0:\n                    self.vegf_field[cell.xCOM, cell.yCOM, cell.zCOM] -= 0.1\n\nCompuCellSetup.register_steppable(steppable=VascularSimulation(frequency=1))\nCompuCellSetup.run()\n```"
    }
  ],
  "outputs": {},
  "metadata": {
    "experiment_model_type": "reasoning",
    "model_type": "reasoning",
    "model_name": "deepseek-ai/deepseek-r1",
    "thinking_process": "<think>\nOkay, I need to generate a CompuCell3D simulation file based on the given ontology annotations. Let's start by breaking down the requirements.\n\nFirst, the user specified several Cell Ontology terms, mainly endothelial cells. So the simulation should include this cell type. Maybe define it in the XML or directly in the Python code. Since the code needs to be self-contained, I'll set up the cell types in the start method.\n\nLooking at the Gene Ontology terms: vasculogenesis, angiogenesis, VEGF signaling, cell proliferation, proteolysis, and extracellular matrix organization. These processes suggest that the simulation should involve cell movement, growth, maybe some chemotaxis towards a growth factor, and ECM interactions. I'll need to include a VEGF field for chemotaxis and possibly ECM degradation via proteolysis.\n\nThe MeSH terms mention Vascular Development, Extracellular Matrix, Growth Factors (like VEGF), Endothelial Cells, and Thalidomide. Thalidomide is known for inhibiting angiogenesis, so maybe include a drug effect, but the user didn't specify, so perhaps just the basic elements. Focus on VEGF and ECM.\n\nNow, the structure of a CompuCell3D simulation file: imports, simulation class inheriting from SteppableBasePy, __init__, start, step methods. Also, basic cell types and parameters based on the ontology.\n\nStart by importing necessary modules: CompuCellSetup, steppables, and maybe cc3d for core elements.\n\nIn the simulation class, the __init__ method should call the parent's __init__. The start method is where I'll set up the cell types (endothelial), configure the volume and contact energy parameters. Also, add a chemical field for VEGF.\n\nIn the step method, implement cell behaviors: proliferation (maybe using the length constraint to grow and divide), chemotaxis towards VEGF, and possibly ECM degradation (though that might require more complex handling, like modifying the field or cell motility based on ECM).\n\nSet up the XML parameters via the generate_xml_config method. Include plugins for Volume, Contact, Chemotaxis (towards VEGF), and maybe LengthConstraint for proliferation. Also, add a steppable for the simulation class.\n\nMake sure the code is valid, includes all required parts, and doesn't have any extra explanations. Check for correct method names and parameters. Use the correct syntax for adding cell types, setting up fields, and configuring plugins.\n</think>",
    "cc3d_file_creation": {
      "python_code": "from cc3d.core.PySteppables import *\n\nfrom cc3d import CompuCellSetup\nfrom cc3d.core.PySteppables import SteppableBasePy, Dim3D\nfrom cc3d.core.XMLUtils import ElementCC3D\n\nclass VascularSimulation(SteppableBasePy):\n    def __init__(self, frequency=1):\n        super().__init__(frequency)\n        self.vegf_field = None\n        \n    def start(self):\n        # Define cell types\n        self.cell_type_endothelial = self.new_cell_type(\"Endothelial\")\n        \n        # Configure basic cell parameters\n        volume_params = ElementCC3D(\"VolumeEnergyParameters\")\n        volume_params.ElementCC3D(\"TargetVolume\", {}, 25)\n        volume_params.ElementCC3D(\"LambdaVolume\", {}, 2.0)\n        self.cc3d.addElement(volume_params)\n        \n        contact_params = ElementCC3D(\"ContactEnergy\")\n        contact_params.ElementCC3D(\"Energy\", {\"Type1\": \"Medium\", \"Type2\": \"Endothelial\"}, 5)\n        contact_params.ElementCC3D(\"Energy\", {\"Type1\": \"Endothelial\", \"Type2\": \"Endothelial\"}, 15)\n        self.cc3d.addElement(contact_params)\n        \n        # Add VEGF chemotaxis\n        self.vegf_field = self.add_chemical_field(\"VEGF\")\n        chemotaxis_params = ElementCC3D(\"Chemotaxis\")\n        chemotaxis_plugin = chemotaxis_params.ElementCC3D(\"Plugin\", {\"Name\": \"Chemotaxis\"})\n        chem_data = chemotaxis_plugin.ElementCC3D(\"ChemicalField\", {\"Name\": \"VEGF\"})\n        chem_data.ElementCC3D(\"Lambda\", {}, 1000)\n        self.cc3d.addElement(chemotaxis_params)\n        \n        # Configure cell cycle and proliferation\n        length_constraint = ElementCC3D(\"LengthConstraint\")\n        length_constraint.ElementCC3D(\"Length\", {}, 20)\n        self.cc3d.addElement(length_constraint)\n        \n    def step(self, mcs):\n        for cell in self.cell_list:\n            if cell.type == self.cell_type_endothelial:\n                # Simulate VEGF-driven chemotaxis\n                self.chemotaxis_plugin.setLambda(cell, 1000)\n                \n                # Simulate cell proliferation\n                if mcs % 50 == 0 and cell.volume > 30:\n                    self.divide_cell_random_orientation(cell)\n                \n                # ECM degradation through protease activity\n                if mcs % 10 == 0:\n                    self.vegf_field[cell.xCOM, cell.yCOM, cell.zCOM] -= 0.1\n\nCompuCellSetup.register_steppable(steppable=VascularSimulation(frequency=1))\nCompuCellSetup.run()",
      "output_file": "experiments\\batch_reasoning_20250623_220414\\paper_14_A_Computational_20250623_220414\\run_10\\generated_cc3d_model.cc3d"
    }
  }
}